A European interlaboratory testing of three well-known procedures for immunocytochemical detection of epithelial cells in bone marrow.: Results from analysis of normal bone marrow

被引:26
作者
Borgen, E. [1 ]
Pantel, K.
Schlimok, G.
Mueller, P.
Otte, M.
Renolen, A.
Ehnle, S.
Coith, C.
Nesland, J. M.
Naume, B.
机构
[1] Univ Oslo, Natl Hosp, Norwegian Radium Hosp, Dept Pathol, N-0310 Oslo, Norway
[2] Univ Hamburg, Med Ctr, Inst Tumor Biol, D-2000 Hamburg, Germany
[3] Cent Clin Augsburg, Med Clin, Augsburg, Germany
[4] Univ Oslo, Natl Hosp, Norwegian Radium Hosp, Dept Oncol, N-0310 Oslo, Norway
关键词
normal bone marrow; disseminated tumor cells; bone marrow; false positive; immunocytochemistry;
D O I
10.1002/cyto.b.20114
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: This investigation intended to study the unspecific background to be expected in normal bone marrow (BM), comparing three well recognized protocols for immunocytochemical detection of disseminated carcinoma cells. The interlaboratory variation in screening and evaluation of stained cells was analyzed and different screening methods were compared. Methods: BM mononuclear cells (BM MNC) from 48 normal BMs were immunostained in parallel by three participating laboratories. The protocols, based on three different anti-cytokeratin antibodies, have all been in common use for detection of disseminated carcinoma cells: the A45-B/B3 protocol (Hamburg), the CK2 protocol (Augsburg) and the AE1AE3 protocol (Oslo). For all protocols, the immunostained cells were visualized by the same alkaline-phosphatase (AP) detection system (APAAP) followed by detection of the cells by manual screening and by two different automated screening systems (ACIS from Chromavision and MDS1 from Applied Imaging). Detected AP-visualized cells were morphologically classified into unambiguous hematopoietic (Uhc) and questionable cells (Qc, potentially interpreted as tumor cells). Results: Seven of 48 BMs (15%) harbored >= 1 AP-visualized cell(s) among 1 x 10(6) BM MNC, both for the A45-B/B3- and for the AE1AE3 protocol, while for CK2 a higher proportion of BMs (21 BMs; 44%) harbored AP-visualized cells (P < 0.01, McNemar's test). The number of Qc was, for ail protocols, 1 log lower than the total number of AP-visualized cells. On average, the frequency of Qc was 0.04, 0.08, and 0.02 per 10(6) BM MNC with A45-B/B3, CK2 and AE1AE3, respectively, and the number of Qc-positive BMs 1, 4, and 1. The MDS1 screening sensitivity was similar to manual screening, while ACIS detected fewer cells (P < 0.001, McNemar's test). Conclusions: All protocols resulted in AP-visualization of occasional hematopoietic cells. However, morphological classification brings the specificity to a satisfactory high level. Approximately 10% of AP-visualized cells were categorized "questionable". The CK2 protocol turned out less specific than the A45-B/B3 and AE1AE3 protocols. (c) 2006 international Society for Analytical Cytology.
引用
收藏
页码:400 / 409
页数:10
相关论文
共 51 条
[31]  
Müller P, 1998, CYTOMETRY, V33, P492, DOI 10.1002/(SICI)1097-0320(19981201)33:4<492::AID-CYTO15>3.0.CO
[32]  
2-C
[33]   Bone marrow "micrometastases" of epithelial tumors:: detection and clinical relevance [J].
Müller, P ;
Schlimok, G .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2000, 126 (11) :607-618
[34]  
Naume B, 1998, INT J CANCER, V78, P556
[35]   The prognostic value of isolated tumor cells in bone marrow in breast cancer patients:: Evaluation of morphological categories and the number of clinically significant cells [J].
Naume, B ;
Wiedswang, G ;
Borgen, E ;
Kvalheim, G ;
Kåresen, R ;
Qvist, H ;
Janbu, J ;
Harbitz, T ;
Nesland, JM .
CLINICAL CANCER RESEARCH, 2004, 10 (09) :3091-3097
[36]  
Pantel K, 1994, J Hematother, V3, P165, DOI 10.1089/scd.1.1994.3.165
[37]   Occult micrometastasis: enrichment, identification and characterization of single disseminated tumour cells [J].
Pantel, K ;
Otte, M .
SEMINARS IN CANCER BIOLOGY, 2001, 11 (05) :327-337
[38]   DIFFERENTIAL EXPRESSION OF PROLIFERATION-ASSOCIATED MOLECULES IN INDIVIDUAL MICROMETASTATIC CARCINOMA-CELLS [J].
PANTEL, K ;
SCHLIMOK, G ;
BRAUN, S ;
KUTTER, D ;
LINDEMANN, F ;
SCHALLER, G ;
FUNKE, I ;
IZBICKI, JR ;
RIETHMULLER, G .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (17) :1419-1424
[39]   Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients [J].
Pierga, JY ;
Bonneton, C ;
Vincent-Salomon, A ;
de Cremoux, P ;
Nos, C ;
Blin, N ;
Pouillart, P ;
Thiery, JP ;
Magdelénat, H .
CLINICAL CANCER RESEARCH, 2004, 10 (04) :1392-1400
[40]  
REDDING WH, 1983, LANCET, V2, P1271